Why the study?
Do cyclo-oxygenase inhibitors relieve pain and restore microvascular circulation in patients with erythromelalgia and thrombocythemia?
Do cyclo-oxygenase inhibitors relieve pain and restore microvascular circulation in patients with erythromelalgia and thrombocythemia?
Aspirin and indomethacin provide complete relief of erythromelalgia symptoms in patients with thrombocythemia, suggesting a platelet-mediated etiology.
Answers are grounded in this paper and cite their sources.
May relieve erythromelalgia symptoms in thrombocythemia; leaves open confirmation of cyclo-oxygenase inhibition and platelet mechanism in controlled trials.
Erythromelalgia was the presenting symptom in 26 of 40 patients with thrombocythemia in its primary form or when associated with polycythemia vera. The localized painful burning, redness, and warm congestion in the extremities could be accurately documented with thermography. Skin punch biopsy samples taken from the affected areas showed typical arteriolar inflammation, fibromuscular intima proliferation, and thrombotic occlusions. Erythromelalgia often progressed to ischemic acrocyanosis or necrosis in toes or fingers. Complete relief of pain and restoration of microvascular circulation disturbances was obtained with the cyclo-oxygenase inhibitors aspirin and indomethacin, but not with sodium-salicylate or the platelet inhibitors dipyridamole, sulfinpyrazone, ticlopidine, and dazoxiben. The erythromelalgia was alleviated during busulfan-induced remissions of thrombocythemia and its recurrence coincided with relapsing thrombocythemia. These observations suggest a causal relationship between erythromelalgia and thrombocythemia, in which platelet-mediated inflammatory and occlusive arteriolar changes play a part in the etiology of erythromelalgia.
No takes yet. Share an insight, caveat, or question.
Jan Michiels (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: